Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
80 - 100
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<0.1
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<0.1
General Information
Version
1.0
Revision date
2025-06-16
Product name
Levofloxacin Injection in 5% Dextrose
1.2.1 Relevant identified uses
Fluoroquinolone antibiotic for intravenous administration
Emergency telephone
+1-866-562-4708
Icons in SDS
Company Information
company name
WG Critical Care, LLC
e-mail address of the competent person responsible for the Safety Data Sheet
wgccquality@wgcriticalcare.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS-US Classification Respiratory sensitization, Category 1 Skin sensitization, Category 1 H334 H317
2.2 Label elements
GHS-US Labeling
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing mist, spray, or vapors. P272 - Contaminated work clothing must not be allowed out of the workplace. P280 - Wear eye protection, protective gloves and clothing. P284 - In case of inadequate ventilation wear respiratory protection. P302+P352 - If on skin: Wash with plenty of soap and water. P304+P340 - If inhaled: Remove person to fresh air and keep at rest in a position comfortable for breathing. P321 - Specific treatment (see Section 4 of this Safety Data Sheet). P333+P313 - If skin irritation or rash occurs: Get medical advice or attention. P342+P311 - If experiencing respiratory symptoms: Call a poison center or doctor. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents and/or container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulations. 2.3 Hazards associated with known or reasonably anticipated uses This product is a pharmaceutical product designed for administration to a patient by a qualified medical professional. No other uses are anticipated. If this product is used in unforeseeable chemical processes and not used as intended or reasonable, the hazards listed in Section 2.3 cannot cover all chemistries. Therefore, a Process Hazard Analysis (PHA) or other hazard assessment for additional specific end uses should be performed to ensure that hazards are fully understood, and adequate safety measures are in place. See Section 10 for relevant reactivity and stability information.
Other hazards
Exposure may aggravate pre-existing eye, skin, or respiratory conditions
Ingredient(s) with unknown acute toxicity
No data available
2.1 Classification of the substance or mixture
GHS-US Classification Respiratory sensitization, Category 1 H334 Skin sensitization, Category 1 H317
